# Thoracic Oncology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Yul Brynner (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML020-SYN-TD
- Date: 1983-09-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Simon Achterberg, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Leah Morrow, MD, Thoracic Oncology
- Urgency: Urgent, within two weeks

## Referral question

Left upper lobe mass invading the mediastinum with mediastinal nodes and left vocal fold paralysis in a 63-year-old former heavy smoker. Please establish the diagnosis and stage, direct biomarker testing, and advise on first-line treatment. **S**

## Questions for the consultant

1. What is the diagnosis and stage once the PET-CT, brain MRI, and biopsy are done, and is the lytic T10 lesion a metastasis?
2. Is the biomarker testing complete enough to choose treatment (PD-L1 and comprehensive genomic profiling, tissue and plasma), and should treatment wait for it?
3. What first-line systemic therapy do you recommend?
4. Is there a role now for surgery, radiation, or a bone-modifying agent?
5. What immune-related adverse event monitoring should primary care carry out, and what should prompt a call?
6. How should palliative care, symptom management, and his wish to keep performing be built into the plan?

## Pertinent history

Six weeks of a weak, breathy voice; he is a stage actor and singer and has paused his tour. Laryngoscopy today: left vocal fold immobile, no laryngeal mass. CT of the chest, abdomen, and pelvis today: 5.2 cm left upper lobe mass invading the aortopulmonary window fat and abutting the aortic arch and left pulmonary artery, enlarged aortopulmonary window and subcarinal nodes, and a small lytic lesion in T10; no adrenal or liver lesion. Mild morning cough, no hemoptysis, no pain, about 2 kg weight loss. ECOG 1. Former smoker: about 3 packs a day from age 12 until he quit 12 years ago (roughly 115 pack-years). Blood count, sodium, potassium, creatinine (eGFR 92), calcium 9.6, liver tests, and glucose normal. PHQ-9 5. PET-CT and brain MRI ordered for this week, and endobronchial ultrasound biopsy requested. He wants plain facts and to return to performing. **S**

- Yul Brynner was born Yuliy Borisovich Bryner on July 11, 1920, in Vladivostok, Russia. **D**
- He gave varying accounts of his origins, saying at times that he was born on Sakhalin Island, with the year given as 1915 (UPI gives July 11, 1915; another reference gives July 12, 1915, under the name Taidje Kahn). **D**
- He first played the King of Siam in The King and I on Broadway in 1951, won the Academy Award for best actor in the 1956 film, and played the role 4,625 times over 34 years. **D**
- He smoked heavily for decades: UPI reported that at one time he smoked five packs of cigarettes a day, and Cancer Today reports two to four packs a day from the age of 12 and that he quit in 1971. **D**
- In September 1983 he was found to have lung cancer; Cancer Today reports that he had found a lump on his vocal cords and that the tumor was too close to his heart for surgery, and UPI reports that he was treated for lung cancer that month and said he would beat the disease and resume touring. **D**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 13.8 g/dL; White cell count: 7.9 10*3/uL; Platelets: 290 10*3/uL; Sodium: 138 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.9 mg/dL; eGFR: 92 mL/min/1.73 m²; Calcium: 9.6 mg/dL; Albumin: 4 g/dL; ALT: 24 U/L; AST: 22 U/L; Alkaline phosphatase: 98 U/L; Total bilirubin: 0.6 mg/dL; Glucose: 96 mg/dL; PHQ-9: 5. All results are synthetic.

BP 132/80 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 96% on room air; weight 72.4 kg; BMI 22.9 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Staging and tissue diagnosis: FDG PET-CT, brain MRI with contrast, and endobronchial ultrasound-guided needle aspiration of the highest-stage node, with enough tissue for PD-L1 and comprehensive next-generation sequencing, and plasma cell-free DNA testing in parallel. Guideline: CMID: Clinical Monitoring Intelligence Database, lung cancer monograph (2026); NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (2026) **S**
- If bone metastases are confirmed: zoledronic acid 4 mg every 12 weeks after a dental examination, with calcium and vitamin D and calcium and creatinine checks before each dose; palliative radiation only if a lesion becomes painful or threatens fracture. Guideline: CMID: Clinical Monitoring Intelligence Database, lung cancer monograph (2026); NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (2026) **S**
- Tobacco: confirm abstinence at each visit; no cessation treatment needed; record the smoking history for his care team. Guideline: CMID: Clinical Monitoring Intelligence Database, lung cancer monograph (2026); NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (2026) **S**
